• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    Celldex Therapeutics, Inc. (CLDX)

    -NMS
    18.82 0.72(3.95%) Dec 18, 4:00PM EST
    |After Hours : 18.82 0.00 (0.00%) Dec 18, 6:19PM EST
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Net Income (81,550) (59,123) (44,799)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation1,579  2,477  4,178  
    Adjustments To Net Income4,624  2,444  2,596  
    Changes In Accounts Receivables(445)126  154  
    Changes In Liabilities8,553  4,356  1,938  
    Changes In Inventories -   -   -  
    Changes In Other Operating Activities(430)(62)275  
    Total Cash Flow From Operating Activities (67,669) (49,782) (35,658)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(4,219)(303)(509)
    Investments(73,224)(16,895)(1,714)
    Other Cash flows from Investing Activities21  218  68  
    Total Cash Flows From Investing Activities (77,422) (16,980) (2,155)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock301,100  83,784  36,023  
    Net Borrowings(11,029)(3,971)(7,503)
    Other Cash Flows from Financing Activities(472)(55)(86)
    Total Cash Flows From Financing Activities 289,599   79,758   28,434  
    Effect Of Exchange Rate Changes(3)2  (9)
    Change In Cash and Cash Equivalents 144,505   12,998   (9,388)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.